Company Filing History:
Years Active: 2001-2011
Title: Innovator Spotlight: Terri F. Busch
Introduction: Terri F. Busch is a distinguished inventor based in Saint Paul, Minnesota, known for her contributions to the field of pharmaceutical formulations. With a robust portfolio of three patents, she has made significant strides in developing innovative treatments that harness the power of immune response modifiers to address various dermal and mucosal conditions.
Latest Patents: Terri's latest patents are groundbreaking in their application of immune response modifiers. Her work includes pharmaceutical formulations that comprise an array of compounds, including imidazoquinoline amines and thiazolo-quinolineamines, specifically designed to treat dermal associated conditions such as actinic keratosis, postsurgical scars, basal cell carcinoma, atopic dermatitis, and warts. In addition, she has developed formulations aimed at treating mucosal associated conditions, particularly in addressing cervical dysplasias, including cervical intraepithelial neoplasias, by administering therapeutically effective amounts of these compounds to the mucosal surfaces.
Career Highlights: Terri F. Busch is associated with 3M Innovative Properties Company, where her expertise in pharmaceutical innovation has played a pivotal role in advancing medical treatment options. Her research focuses on creating novel topical and pharmaceutical formulations that leverage cutting-edge science to improve patient outcomes.
Collaborations: Throughout her career, Terri has collaborated with notable colleagues such as Raymond D. Skwierczynski and Kenneth R. Phares, working together to advance their shared goals in innovation and research within the pharmaceutical landscape.
Conclusion: Terri F. Busch's contributions to the fields of medicine and pharmaceutical formulations reflect her dedication to innovation and improving health outcomes. Her patents not only showcase her inventive prowess but also her commitment to addressing pressing medical challenges. As she continues her work at 3M Innovative Properties Company, her impact on the industry is sure to grow, paving the way for new therapeutic solutions.